Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2001-05-29
2008-07-01
Hartley, Michael G. (Department: 1618)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S772300
Reexamination Certificate
active
07393840
ABSTRACT:
The present invention relates to formulations based on at least one heparin, glycosaminoglycan or heparinoid and on a formulation base with a lipid component and a polymer component. The use of this formulation as drug form for oral administration of at least one heparin, glycosaminoglycan or heparinoid, and also a process for producing the formulations by mixing the formulation components to form a plastic mixture and, where appropriate, to manufacture the formulations as drug form, advantageously using melt extrusion, are described. The lipid component advantageously has active ingredient-promoting properties, while the polymer component is soluble or swellable. At least parts of the lipid component are embedded in a polymer matrix, preferably in the form of a molecular dispersion. The formulations can form emulsions in water or aqueous liquids.
REFERENCES:
patent: 4656161 (1987-04-01), Herr
patent: 4925673 (1990-05-01), Steiner et al.
patent: 5346701 (1994-09-01), Heiber et al.
patent: 5626869 (1997-05-01), Nyqvist et al.
patent: 5707648 (1998-01-01), Yiv
patent: 6309663 (2001-10-01), Patel et al.
patent: 6387401 (2002-05-01), Rosenberg et al.
patent: 99/42086 (1999-08-01), None
patent: 99/44642 (1999-10-01), None
patent: 01/01960 (2001-01-01), None
XP-000886866, Yeh et al., Phar. Res.,vol. 11, No. 8, 1994.
Serajuddin et al., Bioavailability Enhancement of Poorly Water-Soluble Drugs by Solid Dispersion in Surface Active and . . . , Journees Galeniques, 1997, pp. 43-50.
Leone-Bay et al., Synthesis and Evaluation of Compounds that Facilitate the Gastrointestinal Absorption of Heparin, J Med Chem, 1998, vol. 41(7), pp. 1163-1171.
Bachynsky et al., Factors Affecting the Efficiency of a Self-Emulsifying Oral Delivery System, Drug Development and Industrial Pharmacy, 1997, vol. 23(8), pp. 809-816.
Breitenbach Jörg
Heger Robert
Herr Dieter
Laux Volker
Rosenberg Jörg
BASF - Aktiengesellschaft
Hartley Michael G.
Novak Druce & Quigg LLP
Silverman Eric E.
LandOfFree
Formulation based on heparin, glycosaminoglycan or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Formulation based on heparin, glycosaminoglycan or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Formulation based on heparin, glycosaminoglycan or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3968065